Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

High Risk Newly Diagnosed Multiple Myeloma

Tundra lists 1 High Risk Newly Diagnosed Multiple Myeloma clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07053436

Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma

The Multiple Myeloma Research Consortium (MMRC) Horizon Two trial is a master protocol, multi-center, phase II randomized adaptive platform trial designed to efficiently evaluate multiple investigational therapies in high-risk newly diagnosed multiple myeloma patients using an integrated and patient-centric clinical research platform that enables longitudinal learning and sharing of knowledge and investigates multiple novel therapeutic strategies within one trial platform.

Gender: All

Ages: 18 Years - Any

Updated: 2025-07-08

High Risk Newly Diagnosed Multiple Myeloma